Pune, India -- (SBWIRE) -- 10/24/2018 -- This study researches the market size of Anti-obesity Drugs in United States, European Union and China, presents the Anti-obesity Drugs sales, revenue, market share and growth rate by companies, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.

Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain dieting and physical exercise.

The report analysts forecast the Global Anti-obesity Drugs market to grow at a CAGR of 41.45 percent over the period 2013-2022.

PDF Sample For In-depth Analysis and Forecast - https://www.qyresearch.com/sample-form/form/836339/global-united-states-european-union-and-china-anti-obesity-drugs-market

In 2018, the market size of Anti-obesity Drugs is xx million US$ and it will reach xx million US in 2025, growing at a CAGR of xx% from 2018; while in China, the market size is valued at xx million US$ and will increase to xx million US in 2025, with a CAGR of xx% during forecast period.

In this report, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Anti-obesity Drugs.

In United States, European Union and China market, the following companies are covered:

Merck

Novo Nordisk

Pfizer

Arena Pharmaceuticals

Roche

GlaxoSmithKline

Orexigen Therapeutics

Vivus

Amylin

Alizyme

Boehringer Ingelheim

Eisai

Market Segment by Product Type

Peripherally Acting Anti-obesity Drugs

Centrally Acting Anti-obesity Drugs

Market Segment by Application

Kids

Adults

Key Regions split in this report:

United States

China

European Union

Rest of World (Japan, Korea, India and Southeast Asia)

Browse report Details with Complete ToC- https://www.qyresearch.com/index/detail/836339/global-united-states-european-union-and-china-anti-obesity-drugs-market

The study objectives are:

To analyze and research the Anti-obesity Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

To present the key Anti-obesity Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.

To split the breakdown data by regions, type, companies and applications

To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends, drivers, influence factors in global and regions

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Anti-obesity Drugs are as follows:

History Year: 2013-2018

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025